Fenpiverinium: Difference between revisions
Created page with "{{Drugbox | Watchedfields = changed | verifiedrevid = 443757813 | IUPAC_name = 1-(4-amino-4-oxo-3,3-diphenylbutyl)-1-methylpiperidinium | image = Fenpiverinium.png <!--Clinic..." |
No edit summary |
||
Line 44: | Line 44: | ||
| molecular_weight = 337.48 g/mol | | molecular_weight = 337.48 g/mol | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Fenpiverinium''' is an [[antimuscarinic]]. It is used in [[Spasmalgon]]. Spasmalgon is a [[Bulgaria]]n drug which is combination between [[Pitofenone]] Hydrochloride, Fenpiverinium bromide and [[Metamisol]] sodium. Spasmalgon releases pain and spasms of smooth muscles.<ref>http://www.medicine.bg/lekarstva/spasmalgon</ref> | |||
==References== | |||
{{Reflist|2}} | |||
{{Drugs for functional gastrointestinal disorders}} | {{Drugs for functional gastrointestinal disorders}} | ||
Line 54: | Line 60: | ||
[[Category:Muscarinic antagonists]] | [[Category:Muscarinic antagonists]] | ||
[[Category:Piperidines]] | [[Category:Piperidines]] | ||
[[Category: | [[Category:Drug]] | ||
Revision as of 18:51, 8 April 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H29N2O+ |
Molar mass | 337.48 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Fenpiverinium |
Articles |
---|
Most recent articles on Fenpiverinium Most cited articles on Fenpiverinium |
Media |
Powerpoint slides on Fenpiverinium |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Fenpiverinium at Clinical Trials.gov Trial results on Fenpiverinium Clinical Trials on Fenpiverinium at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Fenpiverinium NICE Guidance on Fenpiverinium
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Fenpiverinium Discussion groups on Fenpiverinium Patient Handouts on Fenpiverinium Directions to Hospitals Treating Fenpiverinium Risk calculators and risk factors for Fenpiverinium
|
Healthcare Provider Resources |
Causes & Risk Factors for Fenpiverinium |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fenpiverinium is an antimuscarinic. It is used in Spasmalgon. Spasmalgon is a Bulgarian drug which is combination between Pitofenone Hydrochloride, Fenpiverinium bromide and Metamisol sodium. Spasmalgon releases pain and spasms of smooth muscles.[1]
References
Template:Drugs for functional gastrointestinal disorders
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Quaternary ammonium compounds
- Muscarinic antagonists
- Piperidines
- Drug